2.4.0.8 Html 79 173 1 false 36 0 false 6 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information true false R2.htm 100010 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (Unaudited) false false R3.htm 100020 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsUnauditedParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) false false R4.htm 100030 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsUnaudited Condensed Consolidated Statements of Operations (Unaudited) false false R5.htm 100040 - Statement - Condensed Consolidated Statements of Comprehensive Loss (Unaudited) Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/StatementCondensedConsolidatedStatementsOfComprehensiveLossUnaudited Condensed Consolidated Statements of Comprehensive Loss (Unaudited) false false R6.htm 100050 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) false false R7.htm 100060 - Disclosure - Description of Business and Summary of Significant Accounting Policies Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPolicies Description of Business and Summary of Significant Accounting Policies false false R8.htm 100070 - Disclosure - Earnings (Loss) Per Share Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureEarningsLossPerShare Earnings (Loss) Per Share false false R9.htm 100080 - Disclosure - Inventory Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureInventory Inventory false false R10.htm 100090 - Disclosure - Long-term Debt Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureLongTermDebt Long-term Debt false false R11.htm 100100 - Disclosure - Legal Proceedings Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureLegalProceedings Legal Proceedings false false R12.htm 100110 - Disclosure - Share-based Compensation Expense Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureShareBasedCompensationExpense Share-based Compensation Expense false false R13.htm 100120 - Disclosure - Other Comprehensive Income (Loss) Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureOtherComprehensiveIncomeLoss Other Comprehensive Income (Loss) false false R14.htm 100130 - Disclosure - Leases Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureLeases Leases false false R15.htm 100140 - Disclosure - Collaborations Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureCollaborations Collaborations false false R16.htm 100150 - Disclosure - Subsequent Event Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureSubsequentEvent Subsequent Event false false R17.htm 100160 - Disclosure - Description of Business and Summary of Significant Accounting Policies (Policies) Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesPolicies Description of Business and Summary of Significant Accounting Policies (Policies) false false R18.htm 100170 - Disclosure - Earnings (Loss) Per Share (Tables) Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureEarningsLossPerShareTables Earnings (Loss) Per Share (Tables) false false R19.htm 100180 - Disclosure - Inventory (Tables) Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureInventoryTables Inventory (Tables) false false R20.htm 100190 - Disclosure - Share-based Compensation Expense (Tables) Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureShareBasedCompensationExpenseTables Share-based Compensation Expense (Tables) false false R21.htm 100200 - Disclosure - Other Comprehensive Income (Loss) (Tables) Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureOtherComprehensiveIncomeLossTables Other Comprehensive Income (Loss) (Tables) false false R22.htm 100210 - Disclosure - Collaborations (Tables) Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureCollaborationsTables Collaborations (Tables) false false R23.htm 100220 - Disclosure - Description of Business and Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureDescriptionOfBusinessAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail Description of Business and Summary of Significant Accounting Policies - Additional Information (Detail) false false R24.htm 100230 - Disclosure - Schedule of dilutive effect of outstanding stock options and restricted stock awards (Detail) Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureScheduleOfDilutiveEffectOfOutstandingStockOptionsAndRestrictedStockAwardsDetail Schedule of dilutive effect of outstanding stock options and restricted stock awards (Detail) false false R25.htm 100240 - Disclosure - Earnings (Loss) Per Share - Additional Information (Detail) Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureEarningsLossPerShareAdditionalInformationDetail Earnings (Loss) Per Share - Additional Information (Detail) false false R26.htm 100250 - Disclosure - Components of Inventories (Detail) Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureComponentsOfInventoriesDetail Components of Inventories (Detail) false false R27.htm 100260 - Disclosure - Long-term Debt - Additional Information (Detail) Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail Long-term Debt - Additional Information (Detail) false false R28.htm 100270 - Disclosure - Legal Proceedings - Additional Information (Detail) Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureLegalProceedingsAdditionalInformationDetail Legal Proceedings - Additional Information (Detail) false false R29.htm 100280 - Disclosure - Summary of Share-Based Compensation Expense (Detail) Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureSummaryOfShareBasedCompensationExpenseDetail Summary of Share-Based Compensation Expense (Detail) false false R30.htm 100290 - Disclosure - Share-Based Compensation Expense by Types of Awards (Detail) Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureShareBasedCompensationExpenseByTypesOfAwardsDetail Share-Based Compensation Expense by Types of Awards (Detail) false false R31.htm 100300 - Disclosure - Total Accumulated Other Comprehensive Income (Loss) (Detail) Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureTotalAccumulatedOtherComprehensiveIncomeLossDetail Total Accumulated Other Comprehensive Income (Loss) (Detail) false false R32.htm 100310 - Disclosure - Leases - Additional Information (Detail) Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureLeasesAdditionalInformationDetail Leases - Additional Information (Detail) false false R33.htm 100320 - Disclosure - Collaborations - Additional Information (Detail) Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureCollaborationsAdditionalInformationDetail Collaborations - Additional Information (Detail) false false R34.htm 100330 - Disclosure - Collaborations - Allocated Arrangement Consideration Based on Percentage of Relative Selling Price of Each Unit (Detail) Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureCollaborationsAllocatedArrangementConsiderationBasedOnPercentageOfRelativeSellingPriceOfEachUnitDetail Collaborations - Allocated Arrangement Consideration Based on Percentage of Relative Selling Price of Each Unit (Detail) false false R35.htm 100340 - Disclosure - Subsequent Event - Additional Information (Detail) Sheet http://www.ctibiopharma.com/20140930/taxonomy/role/DisclosureSubsequentEventAdditionalInformationDetail Subsequent Event - Additional Information (Detail) false false All Reports Book All Reports Element ctic_UpfrontPayment had a mix of decimals attribute values: -5 -3. Element us-gaap_AccruedLiabilitiesCurrent had a mix of decimals attribute values: -5 -3. 'Monetary' elements on report '100220 - Disclosure - Description of Business and Summary of Significant Accounting Policies - Additional Information (Detail)' had a mix of different decimal attribute values. 'Monetary' elements on report '100260 - Disclosure - Long-term Debt - Additional Information (Detail)' had a mix of different decimal attribute values. 'Monetary' elements on report '100320 - Disclosure - Collaborations - Additional Information (Detail)' had a mix of different decimal attribute values. Process Flow-Through: 100010 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Process Flow-Through: Removing column 'Sep. 30, 2013' Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: 100020 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Process Flow-Through: 100030 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Process Flow-Through: 100040 - Statement - Condensed Consolidated Statements of Comprehensive Loss (Unaudited) Process Flow-Through: 100050 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) ctic-20140930.xml ctic-20140930.xsd ctic-20140930_cal.xml ctic-20140930_def.xml ctic-20140930_lab.xml ctic-20140930_pre.xml true true